Get started
Author

Brian H. Rank

Observed names: B H Rank, B. H. Rank, BRIAN H. RANK, Brian H Rank, Brian Rank
Institution: HealthPartners
OpenAlex ID: A5039419156
A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation
1985 · Dale C. Snover, Sally A. Weisdorf, et al. · Human Pathology · 169
How Do House Officers Spend Their Nights?
1989 · Nicole Lurie, Brian Rank, et al. · New England Journal of Medicine · 128
Abnormal redox status of membrane-protein thiols in sickle erythrocytes.
1985 · B H Rank, J Carlsson, et al. · Journal of Clinical Investigation · 126
PDF
Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms
1986 · Robert P. Hebbel, Oded Shalev, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 110
Outpatient diabetes clinical decision support: current status and future directions
2016 · P. J. O'Connor, J. M. Sperl‐Hillen, et al. · Diabetic Medicine · 64
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomies
1992 · Paul A Abraham, Charles E Halstenson, et al. · Clinical Pharmacology & Therapeutics · 22
Executive Physicals — Bad Medicine on Three Counts
2008 · Brian Rank · New England Journal of Medicine · 21
A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors.
2024 · Arkadiusz Z. Dudek, Joyce O'Shaughnessy, et al. · Journal of Clinical Oncology · 15
PDF
Increased adsorption of cytoplasmic proteins to the erythrocyte membrane in ATP‐depleted normal and pyruvate kinase‐deficient mature cells and reticulocytes
1983 · David W. Allen, Jerome D. Groat, et al. · American Journal of Hematology · 10
Post-transfusion Purpura as a Gynecologic Complication
1980 · BRIAN H. RANK, CHARLES GAY, et al. · Obstetrics and Gynecology · 4
Implementing evidence-based practices to improve quality. One medical group's experience.
2005 · Brian H Rank · PubMed · 2
Reticulocytosis: defective reticulin degradation, a case report.
1989 · T Repka, B H Rank · PubMed · 2
A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (NCT06234605).
2025 · Neil J. Shah, Manojkumar Bupathi, et al. · Journal of Clinical Oncology · 1
PDF
Part of the solution. Physicians can and want to improve quality, lower cost of healthcare.
2013 · Brian Rank, Pat Courneya · PubMed · 1
A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with locally advanced (inoperable) or metastatic renal cell carcinoma.
2026 · Neil J. Shah, Manojkumar Bupathi, et al. · Journal of Clinical Oncology
A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (NCT06234605).
2025 · Neil J. Shah, Manojkumar Bupathi, et al. · Journal of Clinical Oncology
Iron compartments associated with sickle RBC membranes: a mechanism for the targeting of oxidative damage.
1989 · S A Kuross, B H Rank, et al. · PubMed
Works count: 17
Citation count: 675
H-index: 9
I10-index: 9
Year
Topic
Type